Together with an interdiziplinary Mannschaft he uncovered the molecular mechanisms of Alzheimer's disease and identified target molecules for therapeutic treatment.We would be pleased if you would allow a cookie to Beryllium Zusammenstellung for analysis purposes in order to optimise our provided information. All data are pseudony
81377 München christian.haass(at)dzne.de +49 89 4400-46549 Areas of investigation/research focus Prof. Haass started to work on Alzheimer's disease (AD) in 1990 at a time, when very little welches known about the cellular mechanisms involved. Based on the pathology, which shows invariably the accumulation and deposition of Amyloid ß-peptid
COURSES Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliquaWe also use third-party cookies that help us analyze and understand how you use this website. These cookies will Beryllium stored hinein your browser only with your consent. You also have the Vorkaufsrecht to opt-out of